Type 1 narcolepsy without cataplexy and treatment progress: a case report.

Area of Science:

• Neurology
• Sleep Medicine
• Epidemiology

Background:

• Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness and other symptoms like cataplexy, sleep paralysis, and hallucinations.
• Misdiagnosis is common, with patients often mistaken for epilepsy, syncope, or psychiatric conditions, delaying appropriate treatment.
• Understanding narcolepsy's presentation and epidemiology is crucial for improving clinical recognition and patient outcomes.

Observation:

• This study presents the first district-level diagnosed case of narcolepsy lacking cataplexy, confirmed by comprehensive medical history, objective examinations, and laboratory tests.
• The Multiple Sleep Latency Test (MSLT) revealed an average sleep latency of 3.1 minutes, with abnormal REM sleep episodes in 4 naps and a mean REM latency of 1.3 minutes.
• A review of narcolepsy research in Mainland China over the past decade indicates a potential increase in incidence following the 2009 H1N1 epidemic.

Findings:

• The case underscores that narcolepsy can present without cataplexy, challenging typical diagnostic criteria and emphasizing the need for broader clinical awareness.
• Objective sleep studies, particularly MSLT, are vital for confirming narcolepsy diagnosis, even in atypical presentations.
• Historical data suggests a possible link between viral epidemics and narcolepsy incidence, warranting further investigation.

Implications:

• Improved diagnostic protocols are needed to reduce misdiagnosis rates and ensure timely treatment for narcolepsy patients.
• Further research is essential to explore potential links between post-viral syndromes and narcolepsy development, including post-COVID-19.
• Current evidence does not support immunotherapy for narcolepsy, necessitating continued exploration of effective therapeutic strategies to enhance patient quality of life.